Femarone 20

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Femarone 20
Generic name
FEMARONE 20
Manufacturer
Wise Essentials LLC
Product type
HUMAN OTC DRUG
SPL set ID
44ea74ce-2ba1-e578-e063-6394a90ab72d
SPL ID
44ea74ce-2ba2-e578-e063-6394a90ab72d
Version
1
Effective date
2025-12-13
Source export date
2026-09-28
Source partition
3
Source file
https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/fd09911bd1bc81f7f2faeb048e63855fe224e494376ae919a0035190e315c050/drug-label-0003-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:20:23
Harmonized routes table
Harmonized routes
TRANSDERMAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS: If pregnant or nursing or if you have a serious medical condition, consult a healthcare professional before using this product. KEEP OUT OF REACH OF CHILDREN Store in a cool, dry place Always consult your healthcare provider before using or if pregnant or nursing. Cease use and seek medical attention if skin irritation or a negative reaction. Keep out of reach of children. Store in a cool, dry place. California Prop 65 Law requires this statement: This product contains progesterone, a chemical known only to the State of California to cause cancer. Cease using this product and seek medical attention if skin irritation or other negative reactions occur.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.